- Home
- OPFI vs PACB Comparison
OPFI vs PACB Comparison
Compare OPFI & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPFI
- PACB
- Stock Information
- Founded
- OPFI 2009
- PACB 2000
- Country
- OPFI United States
- PACB United States
- Employees
- OPFI N/A
- PACB N/A
- Industry
- OPFI Finance: Consumer Services
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- OPFI Finance
- PACB Industrials
- Exchange
- OPFI Nasdaq
- PACB Nasdaq
- Market Cap
- OPFI 336.3M
- PACB 364.2M
- IPO Year
- OPFI N/A
- PACB 2010
- Fundamental
- Price
- OPFI $13.62
- PACB $1.32
- Analyst Decision
- OPFI Buy
- PACB Buy
- Analyst Count
- OPFI 2
- PACB 9
- Target Price
- OPFI $11.75
- PACB $2.06
- AVG Volume (30 Days)
- OPFI 1.4M
- PACB 10.1M
- Earning Date
- OPFI 08-06-2025
- PACB 08-06-2025
- Dividend Yield
- OPFI 7.41%
- PACB N/A
- EPS Growth
- OPFI N/A
- PACB N/A
- EPS
- OPFI N/A
- PACB N/A
- Revenue
- OPFI $305,566,000.00
- PACB $152,357,000.00
- Revenue This Year
- OPFI $112.80
- PACB $3.33
- Revenue Next Year
- OPFI $9.34
- PACB $18.52
- P/E Ratio
- OPFI N/A
- PACB N/A
- Revenue Growth
- OPFI 31.46
- PACB N/A
- 52 Week Low
- OPFI $3.09
- PACB $0.85
- 52 Week High
- OPFI $17.73
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- OPFI 55.01
- PACB 59.61
- Support Level
- OPFI $13.02
- PACB $1.20
- Resistance Level
- OPFI $15.03
- PACB $1.35
- Average True Range (ATR)
- OPFI 0.75
- PACB 0.10
- MACD
- OPFI -0.04
- PACB 0.01
- Stochastic Oscillator
- OPFI 58.95
- PACB 69.64
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.